Senseonics, Inc.
11 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ROME GS System Study (NCT07518004) | Senseonics, Inc. | 2026-02-12 |
| Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature (NCT07386340) | Senseonics, Inc. | 2025-12-29 |
| Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features (NCT05131139) | Senseonics, Inc. | 2021-10-20 |
| Eversense® Non-adjunctive Use Post Approval Study (NCT04836546) | Senseonics, Inc. | 2021-04-13 |
| Post Approval Study of the Eversense® Continuous Glucose Monitoring (NCT03908125) | Senseonics, Inc. | 2019-03-19 |
| PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days (NCT03808376) | Senseonics, Inc. | 2018-12-27 |
Track Senseonics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.